Analysis

The financial performance of Beyond Meat for the third quarter of 2025 has triggered a historic sell-off, sending its stock...

A patient death during a critical Phase 3 study has triggered a severe downturn for gene-editing company Intellia Therapeutics. The...

CytomX Therapeutics finds itself at a critical juncture, presenting investors with a complex picture of near-term financial pressures against a...

A remarkable divergence has emerged for MicroStrategy, the corporate Bitcoin trailblazer. The company's shares are now trading at an unprecedented...

Investor faith in Blackrock TCP Capital continues to deteriorate following the company's latest quarterly disclosure. The specialized lender now faces...

The proposed acquisition of Jamf Holding by Francisco Partners has entered a contentious phase, creating uncertainty for shareholders. While the...

As Meta Platforms pours billions into its artificial intelligence initiatives, the social media behemoth faces intensifying regulatory scrutiny across global...

James Hardie Industries is navigating one of its most volatile periods, with its stock value experiencing a dramatic fall. Despite...

While much of the tech world remains captivated by current artificial intelligence applications, Microsoft is quietly constructing the foundational infrastructure...

The high-flying stock of data analytics firm Palantir has encountered significant turbulence following an extraordinary performance run. After catapulting more...